An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease

Neurogastroenterology and Motility

Volumn 25, Issue 11, 2013, Pages

  Berrill, J W ^a   Gallacher, J ^b   Hood, K ^b   Green, J T ^a   Matthews, S B ^c   Campbell, A K ^b   Smith, A ^d  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c University of Ulster Magee Campus   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cognition; Inflammatory bowel disease; Irritable bowel syndrome

Indexed keywords

CALGRANULIN;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; EDUCATIONAL STATUS; ENTERITIS; FECES ANALYSIS; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTELLIGENCE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEMORY; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VELOCITY;

COGNITION; INFLAMMATORY BOWEL DISEASE; IRRITABLE BOWEL SYNDROME;

ADULT; COGNITION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84884977087     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12219     Document Type: Article

References (39)

1. Drossman DA, Camilleri M, Mayer EA et al. AGA technical review on irritable bowel syndrome. Gastroenterology [Review]. 2002;123:2108-31.
2. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42(Suppl. 17): 41-7.
3. Rubin GP, Hungin AP, Kelly PJ et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000; 14: 1553-9.
4. Kennedy PJ, Clarke G, Quigley EM et al. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev 2012; 36: 310-40.
5. Roberts-Thomson IC, Fon J, Uylaki W et al. Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Rev Gastroenterol Hepatol 2011; 5: 703-16.
6. Bashashati M, Rezaei N, Bashashati H et al. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil 2012; 24: 1102-e566.
7. Capuron L, Fornwalt FB, Knight BT et al. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J Affect Disord 2009; 119: 181-5.
8. Loftis JM, Huckans M, Morasco BJ. Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010; 37: 519-33.
9. Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011; 25: 181-213.
10. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol 1995; 5: 205-16.
11. Sandi C, Pinelo-Nava MT. Stress and memory: behavioral effects and neurobiological mechanisms. Neural Plast 2007; 2007: 78970.
12. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 2011; 93: 385-404.
13. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136: 2003-14.
14. Li W, Dowd SE, Scurlock B et al. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009; 96: 557-67.
15. Gareau MG, Wine E, Rodrigues DM et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60: 307-17.
16. Carbotte RM, Denburg SD, Denburg JA. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol 1995; 22: 863-7.
17. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440-6.
18. Brands AM, Van den Berg E, Manschot SM et al. A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. J Int Neuropsychol Soc 2007; 13: 288-97.
19. Thomas M, Smith A. An investigation into the cognitive deficits associated with chronic fatigue syndrome. Open Neurol J 2009; 3: 13-23.
20. Matthews SB, Waud JP, Roberts AG et al. Systemic lactose intolerance: a new perspective on an old problem. Postgrad Med J 2005; 81: 167-73.
21. Waud JP, Matthews SB, Campbell AK. Measurement of breath hydrogen and methane, together with lactase genotype, defines the current best practice for investigation of lactose sensitivity. Ann Clin Biochem 2008; 45(Pt 1): 50-8.
22. Attree EA, Dancey CP, Keeling D et al. Cognitive function in people with chronic illness: inflammatory bowel disease and irritable bowel syndrome. Appl Neuropsychol 2003; 10: 96-104.
23. Dancey CP, Attree EA, Stuart G et al. Words fail me: the verbal IQ deficit in inflammatory bowel disease and irritable bowel syndrome. Inflamm Bowel Dis 2009; 15: 852-7.
24. Stange EF, Travis SP, Vermeire S et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55(Suppl. 1): i1-15.
25. Van Assche G, Dignass A, Panes J et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27.
26. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 2012; 107: 1474-82.
27. Zigmoid AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
28. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
29. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
30. Gallacher J, Collins R, Elliott P et al. A platform for the remote conduct of gene-environment interaction studies. PLoS ONE 2013; 8: e54331.
31. Nelson HE. National Adult Reading Test (NART): Test Manual. Windsor: NFER-Nelson, 1982.
32. Crawford JR, Parker DM, Stewart LE et al. Prediction of WAIS IQ with the National Adult Reading Test: cross-validation and extension. Br J Clin Psychol 1989; 28: 267-73.
33. Roseth AG, Fagerhol MK, Aadland E et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793-8.
34. Centre for Evidence-based Purchasing. Evidence Review: Value of Calprotectin in Screening Out Irritable Bowel Syndrome. London: NHS Purchasing and Supply Agency, 2010.
35. Langhorst J, Elsenbruch S, Koelzer J et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008; 103: 162-9.
36. Schoepfer AM, Beglinger C, Straumann A et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010; 105: 162-9.
37. Sipponen T, Karkkainen P, Savilahti E et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Aliment Pharmacol Ther 2008; 28: 1221-9.
38. Rey E, Moreno Ortega M, Garcia Alonso MO et al. Constructive thinking, rational intelligence and irritable bowel syndrome. World J Gastroenterol 2009; 15: 3106-13.
39. Whorwell PJ, McCallum M, Creed FH et al. Non-colonic features of irritable bowel syndrome. Gut 1986; 27: 37-40.